Drugs@FDA document
EXCEDRIN (MIGRAINE RELIEF) Label · NDA 020802 SUPPL-40
Drugs@FDA document · HALEON US HOLDINGS · Dec 13, 2021
Key facts
| Drug name | EXCEDRIN (MIGRAINE RELIEF) |
|---|---|
| Document type | Label |
| Application | NDA020802 |
| Submission | SUPPL-40 |
| Company | HALEON US HOLDINGS |
| Document date | Dec 13, 2021 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC)-Packaging Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: